trial

rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

NCTId NCT05671185
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 180 (estimated)
Sponsored by National Taiwan University Hospital
Primary completion 2028-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
180 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2022-12-01
Primary completion
2028-12
Eligibility
ALL · 20 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation

Sponsors

National Taiwan University HospitalLead Sponsor

Investigators

1
Chia-Hao Ma, MDPrincipal Investigator

Sites

1 total
Douliu, Yunlin, Taiwan

Facts & assertions

4 sourced
Enrollment
180
Phase
NA
Primary Completion Date
2028-12
Status
RECRUITING
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation
drug
lead_sponsor
National Taiwan University Hospital
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
investigator
Chia-Hao Ma, MD
person